It has been suggested that CEFs promote the release of IGF‐I via PAPP‐A, which cleaves the complex of IGF‐I and IGFBP‐4 in vitro [50] and activates IGF‐I receptor‐mediated signaling in cancer cells. Here, IGF1R is linked to cancer.